Silver Book Fact

Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s

Fact image

Scheiss M, Suescun J, Ellmore T, et al. Preliminary Report on the Safety and Tolerability of Bone Marrow-Derived Allogenic Mesenchymal Stem Cells Infused Intravenously in Parkinson’s Disease Patients; 2019. https://n.neurology.org/content/92/15_Supplement/S16.008. Accessed June 11, 2019

Reference

Title
Preliminary Report on the Safety and Tolerability of Bone Marrow-Derived Allogenic Mesenchymal Stem Cells Infused Intravenously in Parkinson’s Disease Patients
Publication
Neurology
Publication Date
2019
Authors
Scheiss M, Suescun J, Ellmore T, et al
Volume & Issue
Volume 19, Issue 15S
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Average Annual Direct Medical Costs Per Person with Parkinson’s Disease
     
  • According to the Pharmaceutical Research and Manufacturers of America, because of medical research, the number of Americans with Alzheimer’s could decrease by 3 million in 2025.  
  • Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs…  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 out-of-pocket costs for individuals and families dealing with the…  
  • Stopping the Progress of Parkinson’s Would Save >$440,000 per Person